Analyst Price Targets — ATXS
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| October 15, 2025 10:49 am | — | Wedbush | $13.00 | $11.61 | TheFly | Astria Therapeutics downgraded to Neutral from Outperform at Wedbush |
| October 14, 2025 5:05 pm | — | Jefferies | $13.00 | $11.61 | TheFly | Astria Therapeutics downgraded to Hold from Buy at Jefferies |
| October 1, 2025 1:19 pm | — | Evercore ISI | $26.00 | $7.52 | TheFly | Astria Therapeutics price target raised to $26 from $25 at Evercore ISI |
| May 21, 2024 7:50 am | Hartaj Singh | Oppenheimer | $25.00 | $9.59 | TheFly | Astria Therapeutics price target lowered to $25 from $29 at Oppenheimer |
| March 26, 2024 9:28 am | Hartaj Singh | Oppenheimer | $29.00 | $14.12 | StreetInsider | Astria Therapeutics (ATXS) PT Raised to $29 at Oppenheimer following positive Proof-of-Concept |
| December 19, 2022 6:14 am | — | H.C. Wainwright | $20.00 | $11.81 | Benzinga | HC Wainwright & Co. Maintains Buy on Astria Therapeutics, Raises Price Target to $20 |
No recent news available for ATXS.
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for ATXS.
U.S. House Trading
No House trades found for ATXS.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.